Batm Advanced Communicat... Share Discussion Threads

[kooba] 26/4/2024 12:41

Progress and success of new products after years of r&d and $10m's of investment can only really be gauged in meaningful commercial traction..something that so far is far from convincing in the ever extending inflection points we have been informed of..Batm itself as an investment has not proved a success over just about any timescale and i think taking the share price as a measure of that is most credible...lets hope it changes but i find the give 'em a bit more time argument against that backdrop as being rather generous.Who spends $10ms on creating disruptive technology without any thought on how you might market and sell the products when they are ready for commercial release.Seems to me BATM have.

[bigjon1] 26/4/2024 11:00

Carpet you are clueless, if you honestly think this company has made no progress recently then just sell your shares. It will be your loss in the long run. Another classic investor that is just focusing on the share price and isn't looking at the growth of core divisions such as networking edge, cyber and diagnostics.

[tradeterminator01] 26/4/2024 10:14

same old car1pet with his miserable monotone rant! Think i might start visiting this board as a daily reminder to not take life so seriously.

[fse] 25/4/2024 16:19

Rather premature to criticize the board as they have delivered on several fronts.
Edgility is gaining traction, Cyber business is robust. They have introduced a new diagnostics machine which should do well. ADOR advanced RCA diagnostics platform is a reality and if you were paying attention here you would know the details.
Cemex have expanded a successful partnership.
BATM/Edgility etc have been active in trade shows around the globe.
We are all incredibly disappointed with the current share price level which in no way reflects the situation or the value of their IP.

[car1pet] 25/4/2024 15:09

Only if they replace the current Board. Just look at their record

[bigjon1] 25/4/2024 14:53

It is clear that the middle east tensions is leading to a discounted share price but this won't be the case forever and at some point share price will catch up with the fundamental value, especially as more investors see the growth from core businesses over the coming months/years. BATM just need to continue building - the increase in share price will follow.

[kemche] 25/4/2024 10:45

'blood feud'???? A bit strong! Just toying with the font and oracle of all knowledge. I am sure the profit adjacent boy can take it. He's certainly not shy of dishing it out himself. Simply bants.

[resistance1] 25/4/2024 10:05

FSE dont worry about Kemche these public comments are a 'private blood feud' with another

[robertbarns1] 25/4/2024 02:10

worrying times could see new lows lol

[fse] 25/4/2024 01:52

Kemche if you feel dizzy 🥴 you should sit down is top advice

[robertbarns1] 24/4/2024 20:35

25p - 28p within 12 / 18 months

[kemche] 24/4/2024 20:29

Does anyone have any idea of when the rebalancers are likely to finish?

[fse] 24/4/2024 16:04

Regarding the Mountain Telephone contract this may well see some follow on as Telco systems which is an American company is a member of the RUS initiative which is bringing broadband services to rural America. Only certain companies can bid on these contracts and have to have been pre approved (no Chinese !)
There are probably a lot more Mountain Telephones out there.
Also its a shoe in to provide Edge solution with this provider.



Telco are really busy and will be in Germany mid May.

Visit us at
ANGACOM 2024
May 14-16, 2024 | Cologne, Germany
TELCO SYSTEMS
EDGiLITY
THE CONNECTED INTELLIGENT EDGE
HALL 7 BOOTH
#B50

[fse] 24/4/2024 15:52

Had a chance to go over what I could glean from the ADOR presentation given at Anglonordic by the CEO of Ador Dr Eran Zahavy.

The website is certainly worth looking at and you can get a snapshot on there.


This is all quite far along the path to release. The unit itself is fully functional and has been undergoing trials, one finished successfully . There are numerous patents in existence and I am not aware of specific competition.
ADOR claim this is the only Molecular Syndromic Diagnostics system employing a patented Isothermal Amplification method.

There are many advantages to this type of diagnostics method which is ultimately expected to replace the PCR test. The US Govt and other operators spent a very significant amount of funds to get this to work but were not successful. ADOR have cracked this.

The unit itself is not that large and can realistically be operated in a clinical setting. The sample can be taken by anyone with very limited instruction.
This method analyses multiple pathogens simultaneously for whatever subset panel is chosen .
The panels are represented by cartridges that take the sample and then are put into the unit for analysis. The specific cartridges are designed to identify within that subset
For example respiratory panel will test for @22 known pathogens.
In the past a patient may have to be sampled several times before a specific pathogen is identified and each time there is a wait time.
This unit produces an answer in 30 to 40 minutes typically.
The results can be sent digitally to the requesting doctor at another location.
This is just a better way for diagnostics. The unit will be a huge cost and time saver for Doctors and Hospitals to say nothing about the benefits for patients.

Dr Zvi Marom is the chairman of Ador which explains where his time and effort appear concentrated and maybe why it all looks close to commercialization.
There are 2 more clinical trials planned that we know about. I am not sure what the restrictions would be for introducing an analytics machine into the market. it's not like it's a drug thats ingested.

As far as BATM share price goes if this pans out they do own a significant share. How this will be marketed we dont yet know. They do have the ability with Adaltis that already sells diagnostics equipment for a soft launch. They will need a production partner.

[resistance1] 24/4/2024 15:22

New contract but not edge: Mountain Telephone a top Kentucky provider, has chosen Telco Systems | Edgility multi-100G solution to level up their network infrastructure

[resistance1] 24/4/2024 10:10

Robert - What timeline do you foresee for a turnaround? Not to £1 but to the more sensible 30'-40's? And what will be the triggers? As contracts don't seem to have massive impact but suppose a very large one would do. Will the non core business disposals do it or are we awaiting for the Gaza conflict to end or both?

[robertbarns1] 23/4/2024 22:37

if i can get any more in the low 18p'a i will add more ... one day i hope to see 100p's again

[fse] 22/4/2024 17:36

Thanks resistance will check it out.

[resistance1] 22/4/2024 17:21

Have messaged you FSE with details

[fse] 22/4/2024 17:03

>resistance thanks for posting this not sure where you found it but its suggesting that this is well along the way to commercialization. I dont think any other company has mastered RCA we do know that the US government spent a very great deal of money trying and never succeeded.
Do you know if there is a Link anywhere to his presentation?

"Eran Zahavy, Ph.D.Eran Zahavy, Ph.D.
CEO @ ADOR Diagnostics | PhD, Entrepreneurship, R&DCEO @ ADOR Diagnostics | PhD, Entrepreneurship, R&D

I thoroughly enjoyed introducing NATLab, ADOR's groundbreaking Point of Care system for syndromic diagnostics of infectious diseases, at the ANGLONORDIC life science meeting in London."

[resistance1] 22/4/2024 15:22

From the Anglonordic Life Sciences Conference last week at which a range of exciting breakthroughs were pitched to invited sector investors, institutions and backers, ADOR presented their NatLab. Key summary & highlights below for those looking for further insight into this point of exciting new care diagnostic system:
Natlab is based on the Isothermal Amplification method, which is new (but scientifically proven) and is recognised as significantly superior to PCR testing. It is widely tipped to replace PCR.
ADOR is the only company to employ this new method and get it to work with a patented system.
1 trial has been successfully completed, and another 2 trials (Italy & Greece) will complete in Q4 ’24. 3 trials are required for full validation, and with 1 already successful it is looking good.
The worldwide diagnostic market is worth $32bn for the diseases so far covered. More panels are being added to increase market scope.
The system has many patents worldwide including China/Japan/USA/Europe
The system is commercially ready and production ready after trial completion.
The system allows immediate testing to results for many disease groups in 45 mins. With traditional systems you have to do multiple repeat tests for every disease variant taking time and costing far more.
The system can be used by nursing staff/junior lab technicians at the point of care and is foolproof to operate.
Speed of diagnosis means lives saved and care time reduced
The system allows for huge cost savings, speed and staff cost savings. Staff cost savings probably being the most important by far.

[tradeterminator01] 22/4/2024 10:50

robertbarns1, I agree we need more news to keep the ball rolling if we are to see 30p in then ear future and even new heights.

[resistance1] 19/4/2024 15:03

A key aspect of yesterdays contract win was the point that Edgility replaced Totalplay's existing virtualisation solution, extract here: BATM's platform was selected, following a test phase, to replace Totalplay's incumbent network virtualisation solution, primarily due to Edgility's open architecture that provides customers with complete flexibility regarding their network hardware and software
Clearly Totalplay trialed several of Edgility's rivals and found this to be the best. I hope other ISP's are taking note (and probably running their own trials with Edgility as we speak.)

[car1pet] 19/4/2024 09:34

why would I have a copy? GB is the one who talks incessantly about shorting which he clearly doesn't understand